(NASDAQ: SLGL) Sol Gel Technologies's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 289.31%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 58.77%.
Sol Gel Technologies's revenue in 2025 is N/A.On average, 3 Wall Street analysts forecast SLGL's revenue for 2025 to be $71,299,432, with the lowest SLGL revenue forecast at $68,502,502, and the highest SLGL revenue forecast at $73,397,130. On average, 3 Wall Street analysts forecast SLGL's revenue for 2026 to be $15,004,249, with the lowest SLGL revenue forecast at $14,413,662, and the highest SLGL revenue forecast at $15,444,403.
In 2027, SLGL is forecast to generate $48,589,697 in revenue, with the lowest revenue forecast at $46,684,219 and the highest revenue forecast at $50,018,806.